50 Studies Every Endocrinologist Should Know
Oxford University Press Inc (Verlag)
9780197684702 (ISBN)
- Lieferbar (Termin unbekannt)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
As with all books in the "50 Studies" series, each study was selected using an objective selection criterion that included citations per year, high levels of evidence, clinical studies and trials, and a 3-stage Delphi review by international experts in the field. It is an indispensable reference for fellows, physicians, nurse practitioners, and any primary providers with an interest in endocrinology, as well as those taking both the endocrinology board exam and the Endocrinology, Diabetes, & Metabolism certification exam.
John Interlandi, MD, is a distinguished specialist in Endocrinology, Diabetes & Metabolism, and Internal Medicine. He is a graduate of the Vanderbilt University School of Medicine and completed his Internal Medicine Residency at the Medical College of Wisconsin in Milwaukee. He further honed his expertise through an Endocrine Fellowship at Vanderbilt and Nashville VA Hospitals. Dr. Interlandi has served in various academic roles, including Assistant Clinical Professor of Medicine and Associate Clinical Professor of Medicine at Vanderbilt University. His professional journey also includes significant contributions to medical research and clinical trials. He directed the Hepatic Activation Program at Donelson Hospital from 1992 to 1993 and led the Implantable Insulin Pump Project at the same hospital from 1988 to 1994. Additionally, he was involved in the Glyburide Multicenter Trial with Hoechst Pharmaceuticals and conducted Thyroid Biopsy Molecular Analysis Research at Summit Hospital. Dr. Interlandi has shared his knowledge through invited lectures on Thyroid Ultrasound at the AACE Course in Nashville. He also served on the Eli Global Advisory Board Currently, he works as a Medical Director practicing in Tennessee.
SECTION 1: Conditions caused by Thyroid Damage
Chapter 1: Screening for Thyroid Disease in Early Pregnancy and in Pre-Pregnancy
Chapter 2: Subclinical Hypothyroidism
Chapter 3: Management of Thyroxine in Non-Ablated Patients with Hypothyroidism
Chapter 4: Optimal Thyroid Replacement for the Athyreotic Patient
SECTION 2: Conditions Causing Thyroid Overactivity
Chapter 5: Antithyroid Drugs vs. Ablation in Community Treatment for Graves>' Disease
Chapter 6: Optimum Use of Antithyroid Drugs in Hyperthyroidism
Chapter 7: Risks of I-131 Treatment of Hyperthyroidism
Chapter 8: Hyperthyroidism caused by Amiodarone (AIT)
SECTION 3: Focal and Structural Thyroid Disease
Chapter 9: Selection of Thyroid Nodules to be Biopsied
Chapter 10: Selection of Patients over 45 for Thyroid Biopsy
Chapter 11: Molecular Genomic Testing (MGT) for Indeterminate Thyroid Nodules
Chapter 12: Complication Rate(s) from Thyroidectomy
Chapter 13: Ablation Techniques for Benign or Hot Nodules
Chapter 14: Microscopic Papillary Thyroid Carcinoma (mPTC) and Active Surveillance (AS)
Chapter 15: Optimal Work-up and Surgery for a small, non-metastatic DTCA
Chapter 16: I-131 Treatment for DTCA
SECTION 4: Parathyroid Diseases
Chapter 17: Active Surveillance and/or Medical Therapy for Hyperparathyroidism in Older Patients
Chapter 18: Preoperative Localization of Sporadic Primary Hyperparathyroidism
Chapter 19: Quality of Life after Surgery for Mild/Moderate Sporadic Primary Hyperparathyroidism
Chapter 20: Secondary Hyperparathyroidism, Idiopathic Hypercalciuria, and Bone Density
Chapter 21: Recurrent and/or Persistent Primary Hyperparathyroidism
SECTION 5: Metabolic Bone Disease
Chapter 22: Calcium and Vitamin D Effects on Bone Mass
Chapter 23: Fracture Prevention in Patients with Low Bone Mass
Chapter 24: Pretreatment Evaluation for Osteoporosis
Chapter 25: Evaluation of Fracture Risk in Osteoporosis
Chapter 26: Osteoporosis and Hip Fracture Prevention
Chapter 27: Alendronate and Fracture Risk Reduction
Chapter 28: Hip Fracture in the Elderly with Very Low Bone Density
Chapter 29: Anabolic Agent(s) for Osteoporosis
Chapter 30: Glucocorticoid Osteoporosis
Chapter 31: Osteoporosis in Men
SECTION 6: Adrenal Conditions
Chapter 32: The Importance of Recognizing Hyperaldosteronism
Chapter 33: Effectiveness of Treatment of Hyperaldosteronism
Chapter 34: Screening for Adrenal Insufficiency
Chapter 35: Adrenal Incidentalomas
Chapter 36: Opioid-Induced Endocrine Deficiencies
Chapter 37: Adrenal Insufficiency from Corticosteroid Treatment
Chapter 38: Optimal Testing for ACTH-Dependent Hypercortisolism
SECTION 7: Pituitary Tumors / Hypercortisolism
Chapter 39: Duration of Medical Treatment of Intrasellar Prolactinomas
Chapter 40: Acromegaly Treatment-Surgery, Medication, or What?
Chapter 41: Primary Treatment of Pituitary Hypercortisolism
Chapter 42: Treatment of Recurrent or Persistent Hypercortisolism
SECTION 8: Conditions Caused by Testosterone Deficiency
Chapter 43: Risks of Testosterone Treatment in Older Men
Chapter 44: Male Obesity Secondary Hypogonadism (MOSH)
SECTION 9: Conditions Related to Estrogen Deficiency
Chapter 45: Estrogen Treatment and Cardiovascular Health
Chapter 46: Estrogen Treatment and Skeletal Health
Chapter 47: Estrogen + Progestin vs. Estrogen Alone, and Neoplasia
SECTION 10: Polycystic Ovary Syndrome
Chapter 48: Optimal Differential Diagnosis of PCOS
Chapter 49: Optimal Treatment of Hirsutism in PCOS
Chapter 50: Treatment of Subfertility in PCOS
| Erscheinungsdatum | 19.10.2025 |
|---|---|
| Reihe/Serie | Fifty Studies Every Doctor Should Know |
| Zusatzinfo | 56 Black and White Ilustrations |
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 157 x 229 mm |
| Gewicht | 612 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Radiologie / Bildgebende Verfahren | |
| Studium ► 1. Studienabschnitt (Vorklinik) ► Histologie / Embryologie | |
| ISBN-13 | 9780197684702 / 9780197684702 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
